Leucine
United States · Analytics, Artificial Intelligence, Biotechnology
Leucine is an AI-powered platform that helps pharmaceutical manufacturers in staying compliant and audit-ready while ensuring their medicines reach the patients faster. Using Leucine, the Manufacturing, QA, and QC teams can significantly increase productivity and reduce deviations from cGMP guidelines across thousands of complex regulated workflows from material receipt to batch release. Leuci
Key facts
- Headquarters
- United States
- Employees
- Unknown
- Industries
- Analytics, Artificial Intelligence, Biotechnology
- Status
- Private
- Website
- www.leucine.io
- Company page
Recent activity at Leucine
Leucine funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2023 | Funding Round | $7.0M |
Leadership
- Vivek Gera, CEO
- Mustaq Bijral, Co-founder, CPO
- Sumanth Chinta, Business Head
- Andrew Jiranek, Promoter
- Mustaq Singh Bijral, Founder
Verified email and direct lines for Leucine’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Leucine in the news
- Leucine inhibits degradation of outer mitochondrial membrane proteins to adapt mitochondrial respiration - Nature (Oct 31, 2025)
- Startup Leucine reaps $7M in series A funds to advance AI digital twin platform for manufacturing - Fierce Pharma (Oct 17, 2023)
- 10 Healthy High Leucine Foods - Healthline (Jun 09, 2021)
- The impact of leucine supplementation on body composition and glucose tolerance following energy restriction: an 8-week RCT in adults at risk of the metabolic syndrome - Nature (Nov 03, 2023)
- Identification of a leucine-mediated threshold effect governing macrophage mTOR signalling and cardiovascular risk - Nature (Feb 19, 2024)
- Elevated trimethylamine levels characterize impaired muscle mass response to leucine-enriched protein supplementation in older adults at risk of sarcopenia - Nature (Apr 04, 2026)
- -leucine in two individuals with REM sleep behavior disorder improves symptoms, reverses loss of striatal dopamine-transporter binding and stabilizes pathological metabolic brain pattern—case reports - Nature (Sep 02, 2024)
- O -GlcNAc modification of leucyl-tRNA synthetase 1 integrates leucine and glucose availability to regulate mTORC1 and the metabolic fate of leucine - Nature (May 25, 2022)
Companies similar to Leucine
- Adastra · Analytics, Artificial Intelligence, Biotechnology, Machine Learning, Manufacturing
- Scarlet · Artificial Intelligence, Biotechnology, Machine Learning, Manufacturing
- Matter Machine · Artificial Intelligence, Biotechnology, Machine Learning, Manufacturing
- DeepFine · Analytics, Artificial Intelligence, Machine Learning, Manufacturing
- Corologic · Artificial Intelligence, Biotechnology, Machine Learning, Manufacturing
About Leucine: questions and answers
What does Leucine do?
Leucine is an AI-powered platform that helps pharmaceutical manufacturers in staying compliant and audit-ready while ensuring their medicines reach the patients faster. Using Leucine, the Manufacturing, QA, and QC teams can significantly increase productivity and reduce deviations from cGMP guidelines across thousands of complex regulated workflows from material receipt to batch release. Leuci
Where is Leucine headquartered?
Leucine is headquartered in United States.
Has Leucine raised funding?
Yes. Fundz has recorded 1 funding event for Leucine. The most recent, Funding Round of $7.0M, was in Oct 2023.
Who leads Leucine?
Vivek Gera is a CEO at Leucine.
What is the latest news on Leucine?
On Nov 25, 2025, Leucine launches FDA Tracker Premium in partnership with Rx-360 for consortium members to enhance regulatory compliance.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy